Langilan, Chrisly C.

HRN: 23-58-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/23/2023
08/30/2023
PO
3 Ml
BID
Multiple Soft Tissue Injuries
Waiting Final Action 
08/23/2023
MUPIROCIN 2%, 15G (TUBE)
08/23/2023
08/30/2023
TOPICAL
2%
BID
Multiple Abrasions
Waiting Final Action 
08/27/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/27/2023
08/30/2023
PO
3ml
BID
Abrasions
Waiting Final Action 
08/27/2023
MUPIROCIN 2%, 15G (TUBE)
08/27/2023
08/30/2023
TOPICAL
NA
BID
Abrasions
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: